Xenetic Biosciences

Xenetic Biosciences

Biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens.

HQ location
London, United Kingdom
Website
xeneticbio.com
Launch date
Employees
2-10 people
Market cap
$5.5m
Enterprise value
$313k
Share price
$3.92 XBIO
Company register number
03213174
https://twitter.com/xeneticbiohttps://www.facebook.com/xeneticbiohttps://www.linkedin.com/company/xenetic-biosciences-inc-/
    • Edit
loading funding rounds…
Baxter International
Baxter International
University College London
University College London

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2021202220232024202520262027
Revenues0000000000000000000000000000
% growth166 %47 %49 %(2 %)7 %11 %(17 %)
EBITDA0000000000000000000000000000
% EBITDA margin(492 %)(392 %)(178 %)(168 %)(159 %)(263 %)(484 %)
Profit0000000000000000000000000000
% profit margin(486 %)(384 %)(163 %)(158 %)(152 %)(253 %)(472 %)
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue273 %279 %138 %132 %---

Source: Company filings or news article, Equity research estimates

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo